Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Buffalo, New York 14263


Purpose:

This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.


Criteria:

Inclusion Criteria: - Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month. - Patients must complain of mild to moderate arthralgia. - Ability to understand and sign informed consent. - Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines. Exclusion Criteria: - Inability to comply with study requirements. - Metastatic breast cancer. - Patients with orthopedic or neuromuscular disorders that preclude participation in exercise. - Rheumatoid arthritis. - History of MI, angina or congestive heart failure. - Pregnant or lactating females. - Patients that are high risk for moderate exercise based on ACSM risk classification. - Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week. - Morbidly obese with BMI ≥ 40


NCT ID:

NCT01236417


Primary Contact:

Principal Investigator
Tracy O'Connor, MD
Roswell Park Cancer Institute


Backup Contact:

N/A


Location Contact:

Buffalo, New York 14263
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.